| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |